Search results

• 2017

  The Use of PARP Inhibitors in Cancer Therapy: Use as Adjuvant with Chemotherapy or Radiotherapy, Use as a Single Agent in Susceptible Patients, and Techniques Used to Identify Susceptible Patients

  Shall, S., Gaymes, T., Farzaneh, F., Curtin, N. J. & Mufti, G., 11 Jul 2017, (E-pub ahead of print) Poly(ADP-Ribose) Polymerase: Methods and Protocols. Springer, Vol. 1608. p. 343-370 28 p. (Methods in Molecular Biology (MIMB); vol. 1608).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
  6 Citations (Scopus)